Found: 19
Select item for more details and to access through your institution.
Cyclosporine pharmacokinetics and pharmacodynamics in African American and white subjects<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 5, p. 317, doi. 10.1067/mcp.2001.115073
- By:
- Publication type:
- Article
Increased drug delivery to the brain by P-glycoprotein inhibition<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 3, p. 231, doi. 10.1067/mcp.2000.109156
- By:
- Publication type:
- Article
CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4<sup>*</sup>1B 5′-promoter region polymorphism<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 1, p. 82, doi. 10.1067/mcp.2000.108506
- By:
- Publication type:
- Article
Effect of CYP3A inhibition on vesnarinone metabolism in humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 5, p. 506, doi. 10.1016/S0009-9236(98)90101-1
- By:
- Publication type:
- Article
Balovaptan vs Placebo for Social Communication in Childhood Autism Spectrum Disorder: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 491, p. N.PAG, doi. 10.1126/scitranslmed.aat7838
- By:
- Publication type:
- Article
Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1‐Year Interim Results from Study SRP‐9001‐103 (ENDEAVOR).
- Published in:
- Annals of Neurology, 2023, v. 94, n. 5, p. 955, doi. 10.1002/ana.26755
- By:
- Publication type:
- Article
Open-Label Assessment of the Effects of Itraconazole and Rifampicin on Balovaptan Pharmacokinetics in Healthy Volunteers.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 11, p. 4720, doi. 10.1007/s12325-020-01491-y
- By:
- Publication type:
- Article
Erratum to: Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update.
- Published in:
- Clinical & Translational Medicine, 2016, v. 5, n. 1, p. 1, doi. 10.1186/s40169-016-0103-8
- By:
- Publication type:
- Article
First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P850, doi. 10.1016/j.jalz.2015.08.013
- By:
- Publication type:
- Article
Erratum to: Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update.
- Published in:
- Clinical & Translational Medicine, 2016, v. 5, n. 1, p. 1, doi. 10.1186/s40169-016-0103-8
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA<sub>A</sub>-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome.
- Published in:
- Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09418-0
- By:
- Publication type:
- Article
Clinical trial considerations on male contraception and collection of pregnancy information from female partners.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 129, doi. 10.1186/1479-5876-10-129
- By:
- Publication type:
- Article
PKPD and cardiac single cell modeling of a DDI study with a CYP3A4 substrate and itraconazole to quantify the effects on QT interval duration.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2020, v. 47, n. 5, p. 447, doi. 10.1007/s10928-020-09696-y
- By:
- Publication type:
- Article
Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87307-7
- By:
- Publication type:
- Article
Morbidity and medication in a large population of individuals with Down syndrome compared to the general population.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Framework Proposal to Follow‐Up on Preclinical Convulsive Signals of a New Molecular Entity in First‐in‐Human Studies Using Electroencephalographic Monitoring.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 968, doi. 10.1002/cpt.1455
- By:
- Publication type:
- Article